Wasima Hassan
Family Medicine · Lafayette, INNPI 1639256191
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 181 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,258 and has fallen 93.3% since, to $85 in 2025.
Across 181 payments — averaging $14.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$426
- Pfizer$313
- Amgen$241
- Boehringer Ingelheim$234
- AbbVie$234
- Lilly USA, LLC$210
- plus $956 from 18 others
What the payments were for
- Food & beverage$2,601100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 17 | $426 |
| Pfizer | 30 | $313 |
| Amgen | 12 | $241 |
| Boehringer Ingelheim | 18 | $234 |
| AbbVie(2 entities) | 21 | $234 |
| Lilly USA, LLC | 11 | $210 |
| Johnson & Johnson | 21 | $193 |
| Novo Nordisk | 14 | $189 |
| Astellas Pharma US Inc | 6 | $100 |
| GSK | 5 | $71 |
| Dexcom, Inc. | 4 | $70 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $69 |
| Abbott | 4 | $67 |
| Supernus Pharmaceuticals, Inc. | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| Sanofi-aventis U.S. LLC | 2 | $25 |
| Merck | 2 | $23 |
| Amarin Pharma, Inc. | 1 | $17 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Avanir Pharmaceuticals, Inc. | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Clarus Therapeutics Inc. | 1 | $13 |
| Novartis | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
How this compares
$2,613 in reported general payments places this provider in the 75th percentile of 2,709 family medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sertraline Hcl | 13 | $252 |
| Metoprolol Tartrate | 12 | $148 |
| Memantine Hcl | 11 | $105 |
| Citalopram HbrCitalopram Hydrobromide | 11 | $47 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Lafayette
- William BrayLafayette$161K
- Richard TannerIndianapolis$1.6M
- James AndryBloomington$715K
- Richard FeldmanIndianapolis$476K
- Anthony InzerelloEvansville$308K
- Joe BanksIndianapolis$294K
- Steven GatewoodElwood$281K
- Shekar PushpalaCarmel$239K
- Victoria MoyerKokomo$188K
- Thomas KintanarFort Wayne$185K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.